Studies on the mode of action of RC4, a new anticancer agent containing ethyleneimino ring. II. On the inverse relationship between inhibitory activity on anaerobic glycolysis and anticancer effect of RC4 on Ehrlich ascites tumor cells.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D050260:Carbohydrate Metabolism; D002241:Carbohydrates; D002286:Carcinoma, Ehrlich Tumor; D006019:Glycolysis; D019736:Prostheses and Implants
D000970:Antineoplastic Agents; D002241:Carbohydrates
ANTINEOPLASTIC AGENTS/pharmacology; CARBOHYDRATES/metabolism